World | Breaking News & Analysis | The Sydney Morning Herald
Subscribe
Advertisement
Donald Trump and Joe Biden continue to campaign in
earnest. The so-called ‘‘naked ballots’’ could have major consequences given Americans are expected to vote by mail in bigger numbers than ever before because of the pandemic.

'Naked ballots' and Ginsburg's death set to collide in the US election

It's entirely possible a new Supreme Court justice appointed by US President Donald Trump will play a major role if results are tight after the ballots close.

  • by Matthew Knott

Opinion & Perspectives

Advertisement

North America

Harry and Meghan

Trump engages in another round of woman whack-a-mole

It’s a surprise Donald Trump took this long to insult Meghan Markle – she’s been uppity for a while and the President loves to use his office to attack that genre of woman.

  • by Jacqueline Maley
Donald Trump and Joe Biden continue to campaign in
earnest. The so-called ‘‘naked ballots’’ could have major consequences given Americans are expected to vote by mail in bigger numbers than ever before because of the pandemic.

'Naked ballots' and Ginsburg's death set to collide in the US election

It's entirely possible a new Supreme Court justice appointed by US President Donald Trump will play a major role if results are tight after the ballots close.

  • by Matthew Knott

Europe

Advertisement

Asia

BEIJING, CHINA - SEPTEMBER 24: A worker checks vials of potential COVID-19 vaccine CoronaVac on the production line at Sinovac Biotech during a media tour on September 24, 2020 in Beijing, China. Sinovacs inactivated vaccine candidate, called CoronaVac, is among a number of companies in the global race to control the coronavirus pandemic.  The company is running Phase 3 human trials in four countries and ramping up production to 300 million doses per year at a new manufacturing facility south of Beijing.  A lack of domestic coronavirus cases in China has meant that companies developing vaccines have shifted their focus overseas to conduct trials to gather the volume of data necessary to win regulatory approvals. When Chinas government launched an emergency use program in July to vaccinate groups of essential workers, Sinovacs chief executive says the company supplied tens of thousands of doses, even as trials are still underway.  About 90% of Sinovacs employees have chosen to receive injections of CoronaVac, which is one of eight Chinese vaccine candidates in human trials. The company is also seeking approval to begin clinical trials with teenagers and children as young as age 3.  (Photo by Kevin Frayer/Getty Images)

China pushes emergency use of COVID-19 vaccine to thousands despite concerns

It's an unusual move that raises ethical and safety questions, as companies and governments worldwide race to develop a vaccine that will stop the spread of the new coronavirus.

  • by Huizhong Wu and Sam McNeil
Pakistani PM Imran Khan speaks in a pre-recorded message played during the 75th session of the UN General Assembly on Friday.

Imran Khan accuses India of sponsoring Muslim hate

He also criticised other countries' "targeting of Muslims" in the "name of free speech" but stopped short of faulting China for persecuting Uighurs.

  • by Munir Ahmed and Aya Batrawy

Also in World

Marijuana plants growing at a facility in Baton Rouge, Louisiana.

Reefer-endum? NZ's marijuana vote and how it could affect Australia

Will New Zealanders vote to legalise marijuana? Here's what a 'yes' vote means for Australia.

  • by James Massola

Popular in World

Loading
Advertisement